References
- Abu-Farha, M., Al-Mulla, F., Thanaraj, T. A., Kavalakatt, S., Ali, H., Abdul Ghani, M., & Abubaker, J. (2020). Impact of diabetes in patients diagnosed with COVID-19. Frontiers in Immunology, 11, 576818. https://doi.org/10.3389/fimmu.2020.576818
- American Diabetes Association. (2018). Economic costs of diabetes in the U.S. in 2017. Diabetes Care, 41(5), 917–928. https://doi.org/10.2337/dci18-0007
- American Diabetes Association. (2022). Standards of medical care in diabetes-2022 abridged for primary care providers. Clinical Diabetes, 40(1), 10–38. https://doi.org/10.2337/cd22-as01
- Center for Disease Control and Prevention. (2022). National diabetes statistics report: Estimates of diabetes and its burden in the United States. US Department of Health and Human Services. https://www.cdc.gov/diabetes/data/statistics-report/index.html
- Fisher, L., Glasgow, R. E., Mullan, J. T., Skaff, M. M., & Polonsky, W. H. (2008). Development of a brief diabetes distress screening instrument. Annals of Family Medicine, 6(3), 246–252. https://doi.org/10.1370/afm.842
- Fisher, L., Hessler, D., Polonsky, W. H., Masharani, U., Guzman, S., Bowyer, V., Strycker, L., Ahmann, A., Basina, M., Blumer, I., Chloe, C., Kim, S., Peters, A. L., Shumway, M., Weihs, K., & Wu, P. (2018). T1-REDEEM: A randomized controlled trial to reduce diabetes distress among adults with type 1 diabetes. Diabetes Care, 41(9), 1862–1869. https://doi.org/10.2337/dc18-0391
- Fisher, L., Hessler, D. M., Polonsky, W. H., & Mullan, J. (2012). When is diabetes distress clinically meaningful? Establishing cut points for the Diabetes Distress Scale. Diabetes Care, 35(2), 259–264. https://doi.org/10.2337/dc11-1572
- Lambrinou, E., Hansen, T. B., & Beulens, J. W. (2019). Lifestyle factors, self-management and patient empowerment in diabetes care. European Journal of Preventive Cardiology, 26(2_suppl), 55–63. https://doi.org/10.1177/2047487319885455
- Lee, A. A., Piette, J. D., Heisler, M., & Rosland, A. M. (2018). Diabetes distress and glycemic control: The buffering effect of autonomy support from important family members and friends. Diabetes Care, 41(6), 1157–1163. https://doi.org/10.2337/dc17-2396
- Lenters-Westra, E., & Slingerland, R. J. (2010). Six of eight hemoglobin HbA1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clinical Chemistry, 56(1), 44–52. https://doi.org/10.1373/clinchem.2009.130641
- Mathiesen, A. S., Egerod, I., Jensen, T., Kaldan, G., Langberg, H., & Thomsen, T. (2019). Psychosocial interventions for reducing diabetes distress in vulnerable people with type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 12, 19–33. https://doi.org/10.2147/DMSO.S179301
- Packer, M. (2018). Have we really demonstrated the cardiovascular safety of antihyperglycemic drugs? Rethinking the concepts of macrovascular and microvascular disease in type 2 diabetes. Diabetes, Obesity & Metabolism, 20(5), 1089–1095. https://doi.org/10.1111/dom.13207
- Perrin, N. E., Davies, M. J., Robertson, N., Snoek, F. J., & Khunti, K. (2017). The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: A systematic review and meta-analysis. Diabetic Medicine: A Journal of the British Diabetic Association, 34(11), 1508–1520. https://doi.org/10.1111/dme.13448
- Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mullan, J., & Jackson, R. A. (2005). Assessing psychosocial distress in diabetes: Development of the diabetes distress scale. Diabetes Care, 28(3), 626–631. https://doi.org/10.2337/diacare.28.3.626
- Presley, C. A., Mondesir, F. L., Juarez, L. D., Agne, A. A., Riggs, K. R., Li, Y., Pisu, M., Levitan, E. B., Bronstein, J. M., & Cherrington, A. L. (2021). Social support and diabetes distress among adults with type 2 diabetes covered by Alabama Medicaid. Diabetic Medicine, 38(4), e14503. https://doi.org/10.1111/dme.14503
- Schmitt, A., Reimer, A., Kulzer, B., Haak, T., Ehrmann, D., & Hermanns, N. (2016). How to assess diabetes distress: Comparison of the Problem Areas in Diabetes scale (PAID) and the Diabetes Distress Scale (DDS). Diabetes Medicine, 33(6), 835–843. https://doi.org/10.1111/dme.12887
- Sweatman, C., Lauerer, J. A., Pruitt, C., & Drayton, S. J. (2017). Major depressive disorder or diabetes-related distress? Screening, evaluation, and treatment in adults with diabetes. The Journal for Nurse Practitioners, 13(3), e117–123. https://doi.org/10.1016/j.nurpra.2016.08.008
- Tareen, R. S., & Tareen, K. (2017). Psychosocial aspects of diabetes management: Dilemma of diabetes distress. Translational Pediatrics, 6(4), 383–396. https://doi.org/10.21037/tp.2017.10.04